In this interview Sune Klint Andersen,Principal Scientist in Drying Processes and Particle Technology in CMC at Novo Nordisk A/S, Denmark, shares his future perspectives on process analytical technology (PAT) & quality by design (QbD) utilisation. Klint Andersen also discusses what impact QbD has on process understanding, product development and product quality and the main challenges encountered when adopting QbD.
Pharma IQ: What is meant by Quality by Design and what are the key busi...
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
Pharma Contract Manufacturing
23 - 25 March 2026
Mercure Hotel MOA Berlin, Germany
Register Now |
View Agenda |
Learn More